Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 2.77 +0.30 (12.15%)
Previous Close $2.47    52 Week High
Open $2.49    52 Week Low
Day High $2.90    P/E N/A 
Day Low $2.47    EPS
Volume 77,664